Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0011 USD | -8.33% | -15.38% | -87.36% |
2023 | Endonovo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
2023 | Endonovo Therapeutics, Inc 's Sofpulse® Secures Taiwan FDA Approval | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ENDONOVO THERAPEUTICS, INC. | Bio Therapeutic Drugs | -8.33% | -15.38% | -87.36% | -92.47% | -99.99% | 415K | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- ENDV Stock
- Charts Endonovo Therapeutics, Inc.
- Comparison Chart